Also in this playlist...
This transcript is automatically generated
A potential breakthrough in the fight against breast cancer researchers finding a drug approved to treat osteoporosis.
Has now been shown to stop the growth of breast cancer cells -- doctor Siegel it's fascinating how this drug was in fact discovered.
When we talk about what this at stake here.
70% of breast cancer is estrogen receptor positive meaning -- and makes the cancer grow right we use a drug called Tamoxifen that blocks the receptors for estrogen it's very effective.
But cancer figures it out and mutates and figures out how to make it inactive or even to turn against in the cancer grows more on to -- Tamoxifen.
We still need to target those -- interceptors.
This drug destroys the receptive this drug can be useful when Tamoxifen has failed.
So Fox News yesterday spoke to doctor McDonald who's the off the -- -- reached.
What we decided -- was rather than wait around to discover brand new drugs which go back and look at drugs -- to be sitting in the drawers for the last ten or fifteen years.
And really made their -- rather remarkable surprise that a drug which -- recently been approved in Europe.
Has all the characteristics of the drug that we really want to treat and stage breast cancer this type of drug which actually destroys the estrogen -- set there.
And has been a holy Grail and it was sitting there all time.
Can you imagine Heather we go back he said and look at drugs that we've been overlooking or for other things now in Europe this is getting approved for osteoporosis so.
Oncologist will be able to use it for breast -- yes there will be clinical trials are you spoke to him yes.
I guess Clinton yesterday and and he was clearly very excited about this -- said it was hopeful for breast cancer patients the next step would be.
Getting clinical trials here in the United States have what do you think the timeframe would be for that.
And well -- last -- I'll switch to David.
This is Eric's favorite question when are people going to be able use right and everyone wants and Europe I think they're going to be able use it over the next six months here it depends on what the FDA -- -- the FDA gets these clinical trials going.
It would be over the next year to.
Well I think what this is one of the reasons why everyone -- on the house call because you know it's bringing their latest medical news to everybody.
This was in action in the Endocrine Society let.
Two days ago in San Francisco.
Fresh data coming in for this particular drug we -- it wears two hats.
In bone it works almost like estrogen and it actually helps you we do bone density.
In breast it works completely opposite -- do it blocks the reset their.
But besides -- -- receptive it destroys it then that's a big part of this so you won't build up resistance for breast cancer and I think that's a big ticket.
FDA obviously is looking into this because there were some side effects of maybe clotting possible stroke they're looking into that some of the hot flashes of the some of the side effects.
But I gotta tell you that's the best part of medicine a lot of medications that we use we use just by who find him by accident.
Or some of the side effects of them are what we use our -- this if if in fact turns out to come to this country.
He would prevent a lot of these breast cancers and also when they become resistance.
The next choice would be chemotherapy.
Now we can use this medication to really slow down the process did they do.
Filter by section